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INTRODUCTION
In mammals, hematopoietic homeostasis is supported by the
balance of the expression of multiple genes specific to each process.
The GATA-1 gene is located on the X-chromosome (Xp11.23) and
encodes a transcription factor that regulates the development of
erythrocytes, megakaryocytic cells, eosinophils, mast cells, and
dendritic cells [1]. GATA-1 protein has three functional domains
(Fig. 1A): an N-terminal transactivation domain (TD), essential for
transcriptional activation activity, a N-terminal zinc finger (NF),
and a C-terminal zinc finger (CF) responsible for the binding to
DNA [1,2]. Accumulating evidence supports the notion that defects
inGATA-1 are linked to hematopoietic disorders. Exon 4 mutations
have been identified in families with dyserythropoietic anemia,
thrombocytopenia, thalassemia, and erythropoietic porphyria [3].
Furthermore, acquired somatic mutations in exon 2, that cause the
loss of the N-terminal TD of GATA-1, have been found in
individuals with Down Syndrome (DS) who developed either
transient myeloproliferative disorder (TMD) or acute megakaryo-
blastic leukemia (AMKL) [4]. These mutations prevent the
synthesis of full-length GATA-1 (GATA-1 FL), but allow for the
synthesis of a short isoform of GATA-1 (GATA-1s), that lacks the
N-terminal TD [4]. Related germline mutations have also been
described. Hollanda et al. [5] reported a c.220G>C mutation in
seven-male members of a family all with anemia and trilineage
dysplasia. Sankaran et al. [6] identified a mutation in two siblings
affected by DBA and another mutation in a third male from a cohort
of 62 additional DBA patients (Table I). Both mutations occur at the
donor splice site of exon 2 in the GATA-1 gene resulting in exon
skipping. Thus only GATA-1s is produced.
DBA is a normochromic–macrocytic anemia characterized by
impaired proliferation/maturation of the erythroid precursors in the
bone marrow. Approximately, 30% of the patients have a
heterogeneous mix of congenital malformations [7]. Sixty percent
of patients carry mutations in genes encoding ribosomal proteins
(RP). Systematic sequencing of all RP genes in patients with DBA
has allowed the identification of mutations in 11 RP genes [8–10].
The remaining 40% of patients have mutations in unknown genes.
MATERIALS AND METHODS
Patients
Analysis of the Italian DBARegistry [11] revealed 23 out of 173
patients eligible for GATA-1 screening. These patients were all
males and lacked mutations/deletions in the most frequently
mutated DBA genes (RPS10, RPS17, RPS19, RPS24, RPS26,
RPL5, RPL11, or RPL35A). Clinical characteristics of this cohort
are presented in Supplementary Table I. DBA diagnoses were made
using the guidelines reported in Vlachos et al. [7] Written informed
consent was provided by all subjects participating in this study.
Sanger Sequencing
The sixGATA-1 exons were screened for mutations in our cohort
using standard PCR-based Sanger sequencing on genomic DNA
extracted from peripheral blood. Coding sequences and exon–
intron boundaries were PCR amplified using GoTaq1 Flexi DNA
Polymerase (Promega, Madison, WI). PCR products were
sequenced in both directions using a Big Dye Terminator v1.1
cycle sequencing kit (Applied Biosystems, Foster City, CA).
Sequencing data were analyzed using Chromas Lite 2.1.1.
RESULTS
One of the 23 patients studied showed a c.2T>C hemizygous
mutation in the initiation codon used to synthetize the GATA-1 FL.
This mutation was inherited from his mother (Fig. 1B). As a
consequence of this change, GATA-1s is the only isoform
Mutations in the hematopoietic transcription factor GATA-1 alter
the proliferation/differentiation of hemopoietic progenitors. Muta-
tions in exon 2 interferewith the synthesis of the full-length isoformof
GATA-1 and lead to the production of a shortened isoform, GATA-1s.
These mutations have been found in patients with Diamond–
Blackfan anemia (DBA), a congenital erythroid aplasia typically
caused by mutations in genes encoding ribosomal proteins. We
sequencedGATA-1 in 23 patients that were negative for mutations in
the most frequently mutated DBA genes. One patient showed a
c.2T>C mutation in the initiation codon leading to the loss of the
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expressed. Support for this view comes from a study of DS
patients with TMD [4] where mutations in the initiation codon for
GATA-1 FL, that cause the loss of the first methionine, including a
c.2T>C mutation, were shown to lead to the exclusive synthesis
of GATA-1s.
Our is the first study that reports a germline mutation in the first
ATG codon of GATA-1 (Fig. 1B).
The proband reported here (Supplementary Table I, patient
number 10) was born at term after an uneventful pregnancy. At the
age of 9 months he developed a severe hyporegenerative anemia
(Hb 5.5 g/dl, MCV 93 fL, reticulocyte count 40,000/ml) and was
referred to us based on a suspected diagnosis of DBA. No somatic
malformations were evident. His erythrocyte adenosine deaminase
activity was slightly increased (1.9U/g Hb, normal values
1 0.2U/g Hb). Leukocytes and platelets were in the normal
range. The bone marrow aspirate showed a selective deficiency in
erythroid precursors without abnormalities of the other hematopoi-
etic lineages. He was treated with a standard dose of prednisone
(2mg/kg/day) for 4 weeks which was gradually reduced. Only a
partial responsewas observed and his hemoglobin level reached 8 g/
dl. Treatment was discontinued after 3 months and his hemoglobin
level persisted between 8 and 9 g/dl without the need of further
treatment including red blood cell transfusion.
At the age of 4 years he developed a progressive three linear
cytopenia. A bone marrow biopsy showed a severe hypocellular
marrow. The karyotype showed mosaicism with a 45XY, -7 clone
(65%) and a further 50XXY, þ3, þ8, þ21 clone. On this basis, he
was diagnosed with Myelodysplastic Syndrome (MDS) after which
he underwent Hematopoietic Stem Cell Transplantation (HSCT)
from an unrelated donor. Ten years posttransplant, the patient is
transfusion independent and in good health.
DISCUSSION
Our study reports a patient with a hyporegenerative macrocytic
anemia with a mutation in GATA-1 that interferes with the
expression of GATA-1 FL, leaving GATA-1s as the sole isoform
expressed. Mutations that abolish the expression of GATA-1 FL
have been previously identified in 10 DBA patients from three
independent families (Table I) [5,6]. These patients showed various
degrees of anemia, with or without an involvement of other
hematopoietic lineages (Table I). Our patient displayed a
progressive trilinear cytopenia evolving to MDS requiring HSCT.
This evolution occurs infrequently in DBA but at an incidence
higher than the general population [12]. Progression to MDS is not
restricted to GATA-1 genotypes since it has also been observed in
patients with mutations in RP genes.
DBA is considered the prototype of ribosomopathies, since the
discovery that a mutation in a RP can lead to the impairment of the
biogenesis and function of the ribosomes.GATA-1 is the first and so
far the only non-ribosomal protein gene that when mutated leads to
DBA. In contrast to ribosomal proteins, whose essential function in
all cells make it difficult to explain such a selective phenotype, a
role forGATA-1 as a causative gene in DBA is much more intuitive.
Given its role in the transcription of a number of genes required for
erythroid development, loss of its transcription activation domain as
occurs in patients with DBA is consistent with the erythroid
phenotype.
Unresolved is the relationship between DBA caused by
mutations in GATA-1 and RPs. It may be possible that RP
haploinsufficiency interferes with the expression of GATA-1 FL.
Alternatively, the pathways involving GATA-1 and ribosome
Fig. 1. GATA-1 mutation; (A) Schematic representation of GATA-1
protein production, Description of normal and alternative translation
initiation sites located at methionine 1 and 84, respectively. The GATA-
1 mutation in the first ATG in exon 2 promotes the production of only
GATA-1 short isoform while in normal condition both isoforms are
produced; (B) Sanger sequencing. Themutation c.2T>C is highlighted
in the box.
TABLE I. Phenotype Associated to the Mutation of Exon 2 of GATA-1
Reference Mutation Patient Hematology
Sankaran et al. [6] c.220G>C Two Brothers Macrocytic anemia with low reticulocyte counts;
mild reduction in neutrophils count
Sankaran et al. [6] c.220delG 1 Anemia without other hematologic abnormalities
Hollanda et al. [5] c.220G>C Seven affected males in a large family Macrocytic anemia and neutropenia
This paper c.2T>C 1 Anemia and progressive three linear hypoplasia
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function may be independent but result in similar phenotypes. The
association of somatic GATA-1 mutations with TMD in patients
with DS, raises concerns regarding risks to patients with DBA
harboring similarmutations inGATA-1.While the sample size is far
too small to calculate relative risks for such progression, the
trilineage cytopenia and outgrowth of myelodysplastic clones
observed in our patient indicate a need for further studies in this area
and the careful surveillance of affected individuals.
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